Literature DB >> 3918041

Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product.

B Malone, T Lee, F Snyder.   

Abstract

[3H]PAF (platelet activating factor or 1-alkyl-2-acetyl-GPC) is converted to 1-alkyl-2-lyso-GPC and 1-alkyl-2-acyl-GPC by rabbit platelets (GPC is sn-glycero-3-phosphocholine). The deacetylation reaction does not involve the transfer of the acetate of PAF to any other lipid class and added exogenous lyso-PAF readily mixes with the cellular pool of the [3H]lyso-PAF intermediate formed from [3H]PAF. [3H]1-Alkyl-2-acyl-GPC produced during the inactivation of [3H]PAF contained primarily the tetraenoic acyl species (approximately 80% of the 3H in this fraction). The source of the arachidonic acid used for the reacylation of the lyso-PAF intermediate is the diacyl species, phosphatidylcholine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918041

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.

Authors:  M Miwa; T Miyake; T Yamanaka; J Sugatani; Y Suzuki; S Sakata; Y Araki; M Matsumoto
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 2.  Platelet-activating factor: receptors and signal transduction.

Authors:  W Chao; M S Olson
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

3.  Platelet-activating factor modulates phospholipid acylation in human neutrophils.

Authors:  J S Tou
Journal:  Lipids       Date:  1987-05       Impact factor: 1.880

4.  Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells.

Authors:  L Churchill; F H Chilton; D Proud
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

5.  Biosynthesis of paf-acether. Paf-acether but not leukotriene C4 production is impaired in cultured macrophages.

Authors:  A Dulioust; E Vivier; N Meslier; R Roubin; I Haye-Legrand; J Benveniste
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

6.  Vitamin E enhances the acylation of 1-O-alkyl-sn-glycero-3-phosphocholine in human endothelial cells.

Authors:  K Tran; A F D'Angelo; P C Choy; A C Chan
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

7.  Dynamics of platelet-activating-factor release and uptake in a human neutrophil suspension.

Authors:  M Cluzel; C A Rohde; D W MacGlashan; B J Undem; F H Chilton
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

8.  Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.

Authors:  W Chao; A Siafaka-Kapadai; D J Hanahan; M S Olson
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

9.  Esterification of 8,11,14-eicosatrienoate and arachidonate into alkylacyl- and diacylglycerophosphocholine by vascular endothelial cells.

Authors:  M D Rosenthal; M E Brown; J E Jones
Journal:  Lipids       Date:  1988-11       Impact factor: 1.880

10.  Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase.

Authors:  M Liu; P V Subbaiah
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.